Clayton Partners’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Clayton Partners’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Buy	+300,000	New	+$1.41M	1%	33

Other funds holding MSOS

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Clayton Partners's MSOS Position: Q2 2026 in Review

Clayton Partners opened a new position in AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2026: 300,000 shares worth $1.52M. The stake represents 1% of the portfolio and ranks #33 among its holdings.

169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

Clayton Partners held 300,000 shares of AdvisorShares Pure US Cannabis ETF worth $1.52M as of Q2 2026.
AdvisorShares Pure US Cannabis ETF was a new Clayton Partners position in Q2 2026.
AdvisorShares Pure US Cannabis ETF made up 1% of Clayton Partners's portfolio in Q2 2026, its #33 holding.
169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Clayton Partners's 13F filing for Q2 2026, filed 14 Aug 2026.